Home > Insider Trading > Filing (0001127602-23-027356)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1145197	Insulet Corp	PODD	Surgical & Medical Instruments & Apparatus (3841)	043523891

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1631895	Shacey Petrovic	C/O Insulet Corporation 100 Nagog Park Acton MA 01720		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-11-13	11,838	$74.50	14,405	No	4	M	Direct
Common Stock	Acquisiton	2023-11-13	8,162	$92.11	22,567	No	4	M	Direct
Common Stock	Disposition	2023-11-13	2,075	$165.02	41,130	No	4	S	Indirect	By NG Trust
Common Stock	Disposition	2023-11-13	12,925	$165.02	0	No	4	S	Indirect	By SP Trust
Common Stock	Disposition	2023-11-13	20,000	$164.33	2,567	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	S	Indirect	By NG Trust
No	4	S	Indirect	By SP Trust
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2023-11-13	11,838	$0.00	11,838	$74.50
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2023-11-13	8,162	$0.00	8,162	$92.11

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2028-02-14	No	4	M	Direct
11,609		2029-02-26	No	4	M	Direct

Footnotes

The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $164.02 to $164.85. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
This option, which is fully vested, vested over a four-year period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters.
This option, which is fully vested, vested over a four-year period with 25% of the total award vesting on each of the first, second, third and fourth anniversaries of the grant date.